See today's BioWorld Asia
To read the full story, subscribe or sign in.

China-U.S. collaboration set up to explore COVID-19 vaccine possibility

March 31, 2020
By David Ho
HONG KONG – Chengdu, China-based Clover Biopharmaceuticals Inc. has teamed up with Emeryville, Calif.-based Dynavax Technologies Corp. on a research collaboration to develop a vaccine candidate to prevent COVID-19.
BioWorld Asia Collaboration Vaccine China U.S.